day 1 agenda
| Scientific Program | ||
| Day -1: June (29, 2026) | ||
| Meeting Hall - 1 | ||
| Registrations Open (08:30-09:10) | ||
| Opening Ceremony (09:10-09:30) | ||
| Keynote Talks | ||
| Yifan Li, Shanxi Cancer Hospital, China |
09:30-10:00 | Title: How can precision medicine strategies be integrated into postoperative management for hepatobiliary, pancreatic, and gastric cancers? |
| Jagadananda Ghosh, Henry Ford Health System, United States |
10:00-10:30 | Title: Tribbles 2: A novel molecular target to overcome drug resistance in prostate cancer |
| Natalia Neparidze, Yale University., United States |
10:30-11:00 | Title: Systematic Community Outreach Efforts to Raise Awareness of Myeloma |
| Group Photo & Refreshment Break (11:00-11:20) | ||
| Scientific Session I | ||
| Ana S Neumann, The University of Texas School of Dentistry, United States |
11:20-11:40 | Title: Tobacco Use and Eligibility for Lung Cancer Screening Among Dental Patients at an Academic Institution in Houston, Texas |
| Vimolmas Tansathitaya, College of Sports Science and Technology, Mahidol University, Thailand |
11:40-12:00 | Title: The Impact of Air Pollution on Lung Cancer Deformation: A Look at Nitrogen Dioxide Exposure and Long-Term Outdoor Physical Activity |
| Zhenqiang Yao, University of Rochester Medical Center, United States |
12:00-12:20 | Title: Localized apoptosis induction as a new strategy in solid cancer treatment |
| Melinda Ildiko Mitranovici, George Emil Palade University of Medicine, Romania |
12:20-12:40 | Title: Autophagy and its Dual Role, Similitudes and Differences between Trophoblast Cells and Cancer Stem Cells, a Narrative Review |
| Jun Lu, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, China |
12:40-13:00 | Title: Remodeling the tumor immune microenvironment through MEK/RTKs co-inhibition to overcome immunotherapy resistance in KRAS-mutant NSCLC |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Scientific Session II | ||
| Thorsten Schaefer, University and University Hospital Basel, Switzerland |
14:00-14:20 | Title: New insights into the functional significance of stem cell factor and oncogene SOX2 |
| Evangelia Florou, Kings College Hospital, United Kingdom |
14:20-14:40 | Title: Exceptional responders in advanced pancreatic cancer: rethinking resectability and tumour biology |
| Gulcin Ertas, SBÜ Ankara Oncology Training and Researche Hospital, Turkey |
14:40-15:00 | Title: General features of metaplastic breast carcinoma and case of bilateral squamous cell MBC |
| Filippo Dell’Anno, Istituto Zooprofilattico sperimentale Piemonte, Liguria e Valle d'Aosta, Italy |
15:00-15:20 | Title: Environmental Pollution as a Driver of Cancer in Pets: Insights from Canine and Feline Epidemiology |
| Aisha Swaih, AstraZeneca, United Kingdom |
15:20-15:40 | Title: Discovery of a highly selective and blood-brain barrier penetrant irreversible TKI targeting EGFRExon20 Insertions |
| Junfang Zheng, Capital Medical University, China |
15:40-16:00 | Title: KAT8-mediated MDH2 lactylation promotes renal cancer progression by enhancing mitochondrial function and stress resistance |
| Refreshment Break(16:00-16:10) | ||
| Haihe Wang, Sun Yat-sen University, China |
16:10-16:30 | Title: Roles of a small adaptor SH3BGRL in metastasis and chemo-resistance of breast tumor cells |
| Wan-Sheng Liu, The Pennsylvania State University, United States |
16:30-16:50 | Title: Shared RAR Pathway Mechanisms of PRAME Cancer/Testis Antigens in Germ Cells and Tumors |
| Arnon Blum, Ariel University, Israel |
16:50-17:10 | Title: RV size may predict death in unstable patients with PE |
| Sunanda Samanta, Indian Institute of Technology Indore, India |
17:10-17:30 | Title: Deciphering Syk regulation through molecular simulations: conformational dynamics, mutation-induced perturbations, and therapeutic implications |
| Speaker Slot Available | 17:30-17:50 | Speaker Slot Available |
| Pannel Discussions | ||
| Please note that this program is tentative, and the timings are subject to change. | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
day 2 agenda
| Scientific Program | ||
| Day -2: June (30, 2026) | ||
| Meeting Hall - 1 | ||
| Keynote Talks | ||
| Ernest Kaninjing, Georgia College and State University, United States |
09:30-10:00 | Title: The Development of a Model of Acculturation and Health Practices Among Sub-Saharan African Men (MAPS) in the United States: a grounded theory study of prostate cancer early detection |
| Shengyun Fang, University of Maryland Baltimore, United States |
10:00-10:30 | Title: Pharmacological Targeting of VDAC Induces Selective Cancer Cell Death |
| Refreshment Break (10:30-10:40) | ||
| Scientific Session III | ||
| Oluwaseun O. Akinduro, Mayo Clinic Florida, United States |
10:40-11:00 | Title: Inhibition of Yes-Associated Protein (YAP) with Verteporfin Enhances Radiosensitivity in Chordoma by Inhibiting the DNA Damage Response Cascade |
| Thukirtha Chelliah, Copenhagen University Hospital, Denmark |
11:00-11:20 | Title: Symptom burden and quality of life in patients with pancreatic and peri-pancreatic cancer at admission to specialized palliative care: a nationwide register-based study in Denmark |
| Ben Chi-Bun Ko, The Hong Kong Polytechnic University, Hong Kong |
11:20-11:40 | Title: HER3 extracellular domain mutations sensitize HER2low breast cancer to Lapatinib and Trastuzumab treatment |
| Abdulaziz Aloliqi, Qassim University, Saudi Arabia |
11:40-12:00 | Title: Identification and deciphering novel compounds dynamics against DTYMK |
| Yi Li, The Affiliated Hospital of Zunyi Medical University, China |
12:00-12:20 | Title: Influence of Frailty on Anesthesia Recovery Time in Elderly Patients Undergoing Curative Colorectal Cancer Resection: A Prospective Study |
| Alessandra Storm Mauricio, Christian Brothers High School, United States |
12:20-12:40 | Title: Cancer awareness in teens: a hybrid cross-sectional survey and informational campaign |
| Bhagyashri Soumya Nayak, Indian Institute of Technology Indore, India |
12:40-13:00 | Title: Therapeutic potential of selected natural compounds in enhancing the efficacy of opioid growth factor in pancreatic ductal adenocarcinoma treatmentNanovesicle-mediated delivery of engineered L-asparaginase variant with enhanced stability and anti-leukemic effect for acute lymphoblastic leukemia treatment |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Poster presentations (14:00-14:40) | ||
| Scientific Session IV | ||
| Chaochao Qin, Guangyuan Traditional Chinese Medicine Hospital, China |
14:40-15:00 | Title: The Multifaceted Roles of Chemokines in the Chronic Pancreatitis-to-Pancreatic Cancer Cascade: Implications for Pathogenesis and Precision Therapy |
| Hritambhra Deshmukh, All India Institute of Medical Sciences (AIIMS) Bhopal, India |
15:00-15:20 | Title: Targeting the tumor-immune axis in colorectal cancer: a multitarget herbal strategy integrating in-silico and in-vitro approaches |
| Sinisa Dovat, Penn State University College of Medicine, United States |
15:20-15:40 | Title: Epigenomic regulation of tumor suppression in high-risk pediatric leukemia |
| Lekhnath Sharma, Indian Institute of Technology Indore, India |
15:40-16:00 | Title: A New Class of Thienopyridine-Based Kinase Inhibitors with Tunable Selectivity toward LIMK2, CDKs, and Aurora A Kinases |
| Refreshment Break(16:00-16:10) | ||
| Sanya Arora, The London Clinic, United kingdom |
16:10-16:30 | Title: Risk-Adapted Real-World Implementation of Tarlatamab Enables Monitoring De-Intensification in Thoracic Oncology Practice |
| Khandu Wadhonkar, Indian Institute of Technology Indore, India |
16:30-16:50 | Title: Exosome-Mediated NF-κb Activation Drives PD-L1 Expression and Macrophage Reprogramming in Colorectal Cancer |
| Speaker Slot Available | 16:50-17:10 | Speaker Slot Available |
| Tileshwar Sahare, Indian Institute of Technology Indore, India |
17:10-17:30 | Title: Nanozyme-Enabled Smartphone Colorimetric Biosensor for Urinary NMP22 Detection in Bladder Cancer |
| Speaker Slot Available | 17:30-17:50 | Speaker Slot Available |
| Poster presentations (14:00-14:40) | ||
| Chen Wu 3rd Affiliated Hospital of Soochow University, China |
WCCRT-I | Title: Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy |
| Badi A Alotaibi King Saud bin Abdulaziz University For Health Sciences, Saudi Arabia |
WCCRT-II | Title: Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters |
| Anurag Agarwal, Betsi Cadwaladr University Health Board, United Kingdom |
WCCRT-III | Title: A Post-surgical Collection Is Not Just a Collection: A Case Report of Colorectal Cancer Metastasis |
| Rihab Khalil, Hospital Of Aix En Provence, France |
WCCRT-IV | Title: A Rare Parotid Gland Metastasis in Pik3ca Mutated Hr+/Her2 Negative Breast Cancer |
| Yongming Wang, Weifang No.2 People’s Hospital, China |
WCCRT-V | Title: Natural Product from Asparagopsis taxiformis for Targeting Colorectal Cancer |
| Maira Seiilgazy, Nazarbaev University, Kazakhstan |
WCCRT-VI | Title: Anticancer activity of artemisia vulgaris and its nanoparticle formulation against glioblastoma |
| Anke Wu, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
WCCRT-VII | Title: Lactate metabolism-driven tumor heterogeneity and molecular signatures in intrahepatic cholangiocarcinoma |
| Closing Ceremony | ||
| Please note that this program is tentative, and the timings are subject to change | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
Virtual Agenda
| Virtual Scientific Program | ||
| Day -2: June (30, 2026) | ||
| Virtual Presentations (Time Zone: CET) | ||
| Fangzhou Liu, Jiangsu Cancer Hospital, China |
11:00-11:20 | Title: COX5A promotes cell progression and cisplatin-resistance by alleviating mitochondrial dysfunction in head and neck squamous cell carcinoma |
| Changying Guo, Jiangxi Cancer Hospital, China |
11:20-11:40 | Title: Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database |
| Jiayun Nian, Beijing Hospital of Traditional Chinese Medicine, China |
11:40-12:00 | Title: Anxiety, depression and their associated factors in breast cancer survivors and their primary-caregivers: a cross-sectional study |
| Speaker Slot Available | 12:00-12:20 | Speaker Slot Available |
| Shuai Tan, Capital Medical University, China |
12:20-12:40 | Title: From a 2026 perspective: Platelet count ≠ its immunomodulatory function |
| Speaker Slot Available | 12:40-13:00 | Speaker Slot Available |
| Speaker Slot Available | 13:00-13:20 | Speaker Slot Available |
| Veni Subramanyam, Mahatma Gandhi Medical Advanced Research Institute (MGMARI), India |
13:20-13:40 | Title: Nanophytosome-Engineered β-1,3-Glucan and Euglena gracilis: A Multitarget Epigenetic Strategy to combat Ovarian Cancer |
| Speaker Slot Available | 13:40-14:00 | Speaker Slot Available |
| Nuray Alaca, Acibadem University, Turkey |
14:00-14:20 | Title: The effect of manual lymph drainage on breast edema occurring after breast-conserving surgery and radiotherapy in breast cancer patients: a preliminary randomized controlled study |
| João Paulo Kawaoka Matushita Junior, AC Camargo Cancer Center, Brazil |
14:20-14:40 | Title: Percutaneous Biliopancreatic Dual-Duct Intervention in Altered Anatomy Using Digital Cholangioscopy |
| Helen Pearson, Cardiff University, United Kingdom |
14:40-15:00 | Title: Investigating BCL3 as a therapeutic target to treat prostate cancer |
| Thomas Joseph Padley, The Liverpool Ocular Oncology Centre, United Kingdom |
15:00-15:20 | Title: Vitreoretinal surgery for intraocular complications following radiotherapy treatment of uveal melanoma |
| Speaker Slot Available | 15:20-15:40 | Speaker Slot Available |
| Veda N. Giri, Veda N. Giri, United States |
15:40-16:00 | Title: Patient-Centered Approaches in the Evolving World of Germline Testing for Prostate Cancer |
| Christina Dieli-Conwright, Harvard Medical School, United States |
16:00-16:20 | Title: Exercise as Medicine in Genitourinary Oncology: Reducing Health Disparities in Prostate Cancer Survivors |
| Shunfu Hu, Southern Illinois University, United States |
16:20-16:40 | Title: Mapping 2022 Cancer Mortality in Illinois?USA: Spatial-Temporal Patterns and Socio-Environmental Correlates |
| Alissa Michelle Wong, The Chinese University of Hong Kong, Hong Kong |
16:40-17:00 | Title: Organoid-based pharmacogenomics reveal therapeutic vulnerabilities in hepatocellular carcinoma |
| Abass Alavi, University of Pennsylvania, United States |
17:00-17:20 | Title: Targeting TAK1 Overcomes Tumour-Intrinsic Resistance to T cell-mediated killing |
| Kalyani Narra, Texas Christian University, United States |
17:20-17:40 | Title: Prostate cancer-related genetic counseling in a safety-net healthcare setting |
| Closing Ceremony | ||
| Please note that this program is tentative, and the timings are subject to change | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||